Related Experiment Videos

Synthetic and structural studies on Pyrularia pubera thionin: a single-residue mutation enhances activity against

Miquel Vila-Perelló1, Andrea Sánchez-Vallet, Francisco García-Olmedo

  • 1Department of Experimental and Health Sciences, Pompeu Fabra University, Dr. Aiguader 80, E-08003 Barcelona, Spain.

FEBS Letters
|February 15, 2003
PubMed

Insights

Chemically synthesized Pyrularia pubera thionin (Pp-TH) showed antimicrobial activity. Mutating Asp32 to Arg32 (Pp-TH(D32R)) enhanced activity against Gram-negative bacteria, suggesting targeted antimicrobial peptide design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Antimicrobial Peptides

Background:

  • Thionins are small, cysteine-rich proteins with diverse biological activities, including antimicrobial properties.
  • Pyrularia pubera thionin (Pp-TH) is a 47-residue peptide characterized by four disulfide bonds and a unique Asp32 residue.

Purpose of the Study:

  • To chemically synthesize Pp-TH and evaluate its antimicrobial activity.
  • To investigate the functional impact of the Asp32 residue by creating and testing an Arg32 mutant (Pp-TH(D32R)).

Main Methods:

  • Chemical synthesis of Pp-TH and its Asp32 to Arg32 mutant (Pp-TH(D32R)).
  • In vitro antimicrobial activity assays against various bacterial pathogens.
  • Structural analysis, including assessment of helical content.

Main Results:

  • Synthesized Pp-TH exhibited antimicrobial activity comparable to the natural peptide.
  • Pp-TH(D32R) demonstrated significantly enhanced antibiotic activity against Gram-negative bacteria.
  • The overall structure of Pp-TH(D32R) was preserved, with only a minor reduction in helical content.

Conclusions:

  • Chemical synthesis is an effective method for producing Pp-TH.
  • The Asp32 residue plays a crucial role in modulating the antimicrobial spectrum of Pp-TH, particularly against Gram-negative bacteria.
  • Targeted modifications of thionin residues can optimize their antimicrobial efficacy, offering potential for novel therapeutic development.

Related Concept Videos